APOE and LRPAP1 gene polymorphism and risk of Parkinson's disease

Neurological Sciences

Volumn 35, Issue 7, 2014, Pages 1075-1081

  Singh, Neeraj Kumar ^a   Banerjee, Basu Dev ^b   Bala, Kiran ^a   Mitrabasu, ^c   Dung Dung, Aldrin Anthony ^a   Chhillar, Neelam ^a  

^a INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

^b UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^c INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

APOE 4 allele; Cholesterol; LDL cholesterol; LRPAP1 I allele; Neurodegenerative disease; Parkinson's disease

Indexed keywords

ADULT; AGED; ALLELE; APOLIPOPROTEIN E GENE; ARTICLE; AUTOANALYZER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENETIC VARIABILITY; HUMAN; LIPID BLOOD LEVEL; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN ASSOCIATED PROTEIN 1 GENE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; BLOOD; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; NONPARAMETRIC TEST; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

APOLIPOPROTEIN E; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN ASSOCIATED PROTEIN;

AGED; APOLIPOPROTEINS E; CHOLESTEROL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN; LIPOPROTEINS, LDL; LOGISTIC MODELS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84903398691     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-014-1651-6     Document Type: Article

References (35)

1. Perl DP, Olanow CW, Calne D (1998) Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration? Ann Neurol 44:S19-S31 (Pubitemid 28423825)
2. Marder K, Tang MX, Cote L, Stern Y, Mayeux R (1995) The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 52:695-701
3. Nussbaum RL, Ellis CE (2003) Alzheimer's disease and Parkinson's disease. N Engl J Med 348:1356-1364 (Pubitemid 36384104)
4. Holtzman DM, Herz J, Bu G (2012) Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med 2:a006312
5. Singh NK, Chhillar N, Banerjee BD, Bala K, Mukherjee AK, Mustafa MD, Mitrabasu (2012) Gene-environment interaction in Alzheimer's disease. Am J Alzheimers Dis Other Demen 27:496-503
6. Tang G, Xie H, Xu L, Hao Y, Lin D, Ren D (2002) Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease. Am J Med Genet 114:446-449 (Pubitemid 34525244)
7. Huang X, Chen PC, Poole C (2004) APOE-[varepsilon]2 allele associated with higher prevalence of sporadic Parkinson disease. Neurology 62:2198-2202 (Pubitemid 38787775)
8. Blázquez L, Otaegui D, Sáenz A, Paisán-Ruiz C, Emparanza JI, Ruiz-Martinez J, Moreno F, Martí-Massó JF, López de Munain A (2006) Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease. Neurosci Lett 406:235-239
9. Ezquerra M, Campdelacreu J, Gaig C, Compta Y, Muñoz E, Martí MJ, Valldeoriola F, Tolosa E (2008) Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease. Neurosci Lett 448:20-23
10. Gao J, Huang X, Park Y, Liu R, Hollenbeck A, Schatzkin A, Mailman RB, Chen H (2011) Apolipoprotein E genotypes and the risk of Parkinson disease. Neurobiol Aging 32:2106.e1-2106.e6
11. Pulkes T, Papsing C, Mahasirimongkol S, Busabaratana M, Kulkantrakorn K, Tiamkao S (2011) Association between apolipoprotein E genotypes and Parkinson's disease. J Clin Neurosci 18:1333-1335
12. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ (1994) Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 272:1666-1671 (Pubitemid 24359137)
13. Alvim RO, Freitas SR, Ferreira NE, Santos PC, Cunha RS, Mill JG, Krieger JE, Pereira AC (2010) APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. Lipids Health Dis 9:128
14. Huang X, Chen H, Miller WC, Mailman RB, Woodard JL, Chen PC, Xiang D, Murrow RW, Wang YZ, Poole C (2007) Lower low density lipid cholesterol levels are associated with Parkinson's disease. Mov Disord 22:377-381 (Pubitemid 46569693)
15. Willnow TE, Armstrong SA, Hammer RE, Herz J (1995) Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Proc Natl Acad Sci USA 92:4537-4541
16. Koob AO, Ubhi K, Paulsson JF, Kelly J, Rockenstein E, Mante M, Adame A, Masliah E (2010) Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies. Exp Neurol 221:267-274
17. Dixit M, Choudhuri G, Keshri LJ, Mittal B (2006) Association of low density lipoprotein receptor related protein-associated protein (LRPAP1) gene insertion/deletion polymorphism with gallstone disease. J Gastroenterol Hepatol 21:847-849 (Pubitemid 43793282)
18. Dixit M, Choudhuri G, Mittal B (2006) Association of lipoprotein receptor, receptor-associated protein, and metabolizing enzyme gene polymorphisms with gallstone disease: a case-control study. Hepatol Res 36:61-69 (Pubitemid 44309282)
19. Sánchez L, Alvarez V, González P, González I, Alvarez R, Coto E (2001) Variation in the LRP-associated protein gene (LRPAP1) is associated with late-onset Alzheimer disease. Am J Med Genet 105:76-78
20. Schutte DL, Maas M, Buckwalter KC (2003) A LRPAP1 intronic insertion/deletion polymorphism and phenotypic variability in Alzheimer disease. Res Theory Nurs Pract 17:301-319
21. Pandey P, Pradhan S, Mittal B (2008) LRP-associated protein gene (LRPAP1) and susceptibility to degenerative dementia. Genes Brain Behav 7:943-950
22. Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J (2007) Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 64:990-997 (Pubitemid 47047999)
23. Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F, Umbach DM, Xu Q, Hollenbeck A, Schatzkin A, Blair A (2010) Smoking duration, intensity, and risk of Parkinson disease. Neurology 74:878-884
24. E O'Reilly EJ, Chen H, Gardener H, Gao X, Schwarzschild MA, Ascherio A (2009) Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality. Am J Epidemiol 169:678-682
25. D Hong DP, Fink AL, Uversky VN (2009) Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation? Biochim Biophys Acta 1794:282-290
26. LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE (1994) Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem 269:23403-23406
27. Gai WP, Yuan HX, Li XQ, Power JT, Blumbergs PC, Jensen PH (2000) In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol 166:324-333
28. Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL (2005) Alphasynuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Brain 128:2654-2664 (Pubitemid 41552949)
29. Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J (2008) Total cholesterol and the risk of Parkinson disease. Neurology 70:1972-1979
30. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U, Danesh J (2007) Association of apolipoprotein E genotype with lipid levels and coronary risk. JAMA 298:1300-1311 (Pubitemid 47443344)
31. Grönroos P, Raitakari OT, Kähönen M, Hutri- Kähönen N, Marniemi J, Viikari J, Lehtimäki T (2007) Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study. Clin Chem Lab Med 45:592-598
32. Addante F, Sancarlo D, Copetti M, Scarcelli C, Longo MG, Niro V, Paroni G, Pellegrini F, Fontana L, Pilotto A (2011) Effect of obesity, serum lipoproteins, and apolipoprotein E genotypes on mortality in hospitalized elderly patients. Rejuvenation Res 14:111-118
33. Huang X, Abbott RD, Petrovitch H, Mailman RB, Ross GW (2008) Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study. Mov Disord 23:1013-1018
34. Tikhonoff V, Casiglia E, Mazza A, Scarpa R, Thijs L, Pessina AC, Staessen JA (2005) Low-density lipoprotein cholesterol and mortality in older people. J Am Geriatr Soc 53:2159-2164 (Pubitemid 43001198)
35. Colpo A (2005) LDL Cholesterol: bad cholesterol or bad science? J Am Physicians Surg 10(3):83-89